Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.55 -0.07 (-4.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Processa Pharmaceuticals (PCSA) Return on Capital Employed [ROCE] (2013 - 2026)

Updated

Processa Pharmaceuticals (PCSA) posted Return on Capital Employed [ROCE] of -1415.52% for Q2 2026, down 1122.44 percentage points from -293.08% a year earlier and down 1069.88 percentage points from the prior quarter.

Analysis

Processa Pharmaceuticals (PCSA) Return on Capital Employed [ROCE] (2013 - 2026) Analysis & Trends

For FY2025, Processa Pharmaceuticals' Return on Capital Employed [ROCE] came in at -425.81%, down 20.77 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for four consecutive years, with a five-year change of -335.86 percentage points (FY2020 to FY2025).
  • In prior years, Processa Pharmaceuticals' Return on Capital Employed [ROCE] was -405.04% in FY2024 (-228.03 pp), -177.01% in FY2023 (-10.62 pp), -166.39% in FY2022 (-117.59 pp) and -48.79% in FY2021 (+41.16 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2013.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in four of the last eight quarters, with an average year-over-year change of -185.48 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2025, with a gain of 215.96 percentage points; the weakest was Q2 2026, with a drop of 1122.44 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -345.64% (Q1 2026), -256.07% (Q4 2025) and -212.34% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Processa Pharmaceuticals 4.53 Mn 4.53 Mn - -1,415.52%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,415.52%
Mar 31, 2026 -345.64%
Dec 31, 2025 -256.07%
Sep 30, 2025 -212.34%
Jun 30, 2025 -293.08%
Mar 31, 2025 -441.76%
Dec 31, 2024 -472.02%
Sep 30, 2024 -233.28%
Jun 30, 2024 -145.80%
Mar 31, 2024 -148.23%
Dec 31, 2023 -184.67%
Sep 30, 2023 -267.00%
Jun 30, 2023 -248.51%
Mar 31, 2023 -339.52%
Dec 31, 2022 -218.22%
Sep 30, 2022 -94.13%
Jun 30, 2022 -69.51%
Mar 31, 2022 -54.14%
Dec 31, 2021 -45.32%
Sep 30, 2021 -66.39%
API Access

Processa Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PCSA&period=max&api_key=YOUR_API_KEY